Taylor Wessing
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Taylor Wessing boasts deep proficiency across all areas of patent law, catering to clients in sectors including life sciences, technology, telecoms, consumer and retail. The department is co-led by Wim Maas, who handles high-stakes patent litigation and IP seizures across the electronics, mechanical engineering, biotechnology, and pharmaceuticals segments. Also co-heading the team is Bas Berghuis van Woortman, who joined in August 2025 and specialises in patent and technology-focused IP litigation, while also advising on licensing, prosecution strategy, R&D agreements, and trade secret protection. Also in August 2025, the team hired Sebastien Versaevel and Diptanil Debbarma, followed by Daisy Termeulen in December 2025. Eelco Bergsma and Charlotte Garnitsch departed the firm.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘We are very happy with the services provided by Taylor Wessing on our patent litigation matters. They are consistently responsive and creative in finding practical solutions, and they clearly understand our commercial interests.’
- 'Wim Maas is widely recognised for his strategic insights: he excels at framing litigation not only in terms of the immediate proceedings but in the broader commercial and competitive context.’
Key clients
- Pfizer Abbott Ericsson Accord Healthcare XPENG Walt Disney Company Tandem Diabetes Care Easee Wensch Product Development Tenways CEAD B.V. Fresenius Glenmark Jovaplant B.V. Rubin Medical JRZ Suspension Engineering B.V. Samsung Bioepis Netherlands Cancer Institute Med-El HP Samsung Electronics Spirits International LinXis Cathay Nederlandse Staat
Work highlights
Acting in Pfizer v. BioNTech and Moderna - high-profile patent litigation concerning the COVID-19 vaccine.